Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.
Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.
复制标题
DOI:
10.3201/eid1901.120741
复制
发表时间:
2013-01
影响因子:
11.8
通讯作者:
Miller E
中科院分区:
文献类型:
--
作者:
Ladhani SN;Slack MP;Andrews NJ;Waight PA;Borrow R;Miller E
Nonvaccine serotypes occur more often among children with comorbid conditions. We assessed known risk factors, clinical presentation, and outcome of invasive pneumococcal disease (IPD) in children 3–59 months of age after introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in England and Wales. During September 2006–March 2010, a total of 1,342 IPD episodes occurred in 1,332 children; 14.9% (198/1,332) had comorbidities. Compared with IPD caused by PCV7 serotypes (44/248; 17.7%), comorbidities were less common for the extra 3 serotypes in the 10-valent vaccine (15/299; 5.0%) but similar to the 3 additional PCV13 serotypes (45/336; 13.4%) and increased for the 11 extra serotypes in 23-valent polysaccharide vaccine (PPV23) (39/186; 21.0%) and non-PPV23 serotypes (38/138; 27.5%). Fifty-two (3.9%) cases resulted from PCV7 failure; 9 (0.7%) case-patients had recurrent IPD. Case-fatality rate was 4.4% (58/1,332) but higher for meningitis (11.0%) and children with comorbidities (9.1%). Thus, comorbidities were more prevalent in children with IPD caused by non-PCV13 serotypes and were associated with increased case fatality.